All NewsBio/Pharma News
All PublicationsPharmTechPharmTech Europe
MarketplaceICH Q9 Revision: A Comprehensive Resource on Quality Risk ManagementPeer-Reviewed ResearchPharmTech ProductsPharma InsightsSponsored PodcastsSponsored VideosSponsored eBooksWhitepapers
Webcasts
All VideosAsk the ExpertBehind The HeadlinesBuy, Sell, HoldDrug Digest VideosDrug Solutions PodcastPeer ExchangeSexy ScienceTech Talk
Conference CoverageConference ListingEvents
Subscribe
AnalyticsAnalyticsAnalytics
Data and Artificial Intelligence
Dosage FormsDosage FormsDosage FormsDosage FormsDosage Forms
Drug DevelopmentDrug DevelopmentDrug DevelopmentDrug DevelopmentDrug DevelopmentDrug Development
ManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturing
OutsourcingOutsourcingOutsourcingOutsourcingOutsourcingOutsourcingOutsourcing
Quality SystemsQuality SystemsQuality SystemsQuality Systems
Spotlight -
  • Analytics
  • Dosage Forms
  • Drug Development
  • Manufacturing
  • Outsourcing
  • Quality Systems
IS1
  • Applied Clinical Trials

  • BioPharm International

  • Cannabis Science and Technology

  • Chromatography Online

  • Nutritional Outlook

  • Pharmaceutical Commerce

  • Pharmaceutical Executive

  • Pharm Tech

  • Spectroscopy Online

  • Turbo Machinery Magazine

AnalyticsAnalyticsAnalytics
Data and Artificial Intelligence
Dosage FormsDosage FormsDosage FormsDosage FormsDosage Forms
Drug DevelopmentDrug DevelopmentDrug DevelopmentDrug DevelopmentDrug DevelopmentDrug Development
ManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturing
OutsourcingOutsourcingOutsourcingOutsourcingOutsourcingOutsourcingOutsourcing
Quality SystemsQuality SystemsQuality SystemsQuality Systems
IS1
  • Applied Clinical Trials

  • BioPharm International

  • Cannabis Science and Technology

  • Chromatography Online

  • Nutritional Outlook

  • Pharmaceutical Commerce

  • Pharmaceutical Executive

  • Pharm Tech

  • Spectroscopy Online

  • Turbo Machinery Magazine

    • Webcasts
    • Subscribe
Advertisement

Article

Equipment and Processing Report

August 20, 2008

Equipment and Processing Report

Equipment and Processing Report-08-20-2008
Volume0
Issue 0

August 2008 Editor's Picks: Products from OYSTAR Manesty and Hawk

Author(s):

Pharmaceutical Technology Editors

PharmTech's monthly newsletter, Equipment & Processing Report, reviews the Editor's Picks for the August 2008 edition from OYSTAR Manesty and Hawk.

OYSTAR Manesty
Tablet press produces scalable results

The fully automated, single-station “Flexitab” tablet press from OYSTAR Manesty (Fairfield, NJ) is designed to produce results similar to those of a rotary press. The device’s two punches are each controlled by one pneumatic and one hydraulic cylinder, which help the unit achieve the same punch travel velocity and force as a rotary press. Scientists can “optimize a formulation with only a small amount of material,” according to Nic Michel, vice-president of OYSTAR USA’s process division.

In addition, the Flexitab machine produces single layer, bilayer, and trilayer tablets. Three hoppers are mounted on the press’s die table. Each hopper has a pneumatically driven slide-feeder mechanism that automatically fills each tablet layer and compresses between each layer.

Michel adds that operators can set the unit’s dwell time and punch displacement and store various compression profiles in the device’s memory.

Hawk
Detectors incorporate adjustable sensitivity

Hawk (Melbourne, Australia) has added microwave-beam blockage-detecting systems to its “Gladiator” series of level-detection switches. The units use microwave energy, which penetrates plastic, glass, ultrahigh-molecular-weight polyethylene, PTFE, firebrick, and ceramic materials. The devices do not suffer from false tripping or fail to respond like traditional tilt switches, according to Hawk.

The system’s sender transmits rapid bursts of microwave energy to a corresponding receiver, which can be mounted as far as 100 m away. The presence or absence of the signal at the receiver switches a relay for indication or control purposes. The detector’s sensitivity is adjustable, and operators can allow the system to tolerate buildup or changes in material properties.

Systems are available in remote and stand-alone configurations and are not intrusive to manufacturing processes. The product is suitable for blocked-chute detection in wet-, dry-, and bulk-material conveying and transfer systems.

Articles in this issue

How to Be Green in a CGMP-Regulated Environment
After Formaldehyde: Comparing Alternative Decontaminants
Hawk_150x155-542946-1408674896197.jpg
August 2008 Editor's Picks: Products from OYSTAR Manesty and Hawk

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!
Related Videos
Dave Miller, PhD, Chief Scientific Officer, AustinPx
Dave Miller, PhD, Chief Scientific Officer, AustinPx
Related Content
Advertisement
Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com
August 16th 2025

In Europe, the Use of Titanium Dioxide in Drugs Will Continue

Susan Haigney
Drug Solutions Podcast: Growth and Advancements in Fill/Finish
August 16th 2025

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com
August 16th 2025

FDA Commissioner Applauds Florida Restriction on 7-OH Opioids

Susan Haigney
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
August 16th 2025

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Feliza Mirasol
Coronavirus 2019-nCov novel coronavirus concept resposible for asian flu outbreak and coronaviruses influenza as dangerous flu strain cases as a pandemic. The virus is made up of purple pills. | Image Credit: © lunarts_studio - stock.adobe.com
August 16th 2025

BARDA Pulls Plug on Vaxart Oral COVID Vaccine Trial After mRNA Rollback

Patrick Lavery
Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com
August 16th 2025

Nxera’s New GLP-1 and GPCR-Targeted Drug Programs Aim to Advance Obesity and Metabolic Disorder Therapies

Feliza Mirasol
Related Content
Advertisement
Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com
August 16th 2025

In Europe, the Use of Titanium Dioxide in Drugs Will Continue

Susan Haigney
Drug Solutions Podcast: Growth and Advancements in Fill/Finish
August 16th 2025

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com
August 16th 2025

FDA Commissioner Applauds Florida Restriction on 7-OH Opioids

Susan Haigney
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
August 16th 2025

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Feliza Mirasol
Coronavirus 2019-nCov novel coronavirus concept resposible for asian flu outbreak and coronaviruses influenza as dangerous flu strain cases as a pandemic. The virus is made up of purple pills. | Image Credit: © lunarts_studio - stock.adobe.com
August 16th 2025

BARDA Pulls Plug on Vaxart Oral COVID Vaccine Trial After mRNA Rollback

Patrick Lavery
Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com
August 16th 2025

Nxera’s New GLP-1 and GPCR-Targeted Drug Programs Aim to Advance Obesity and Metabolic Disorder Therapies

Feliza Mirasol
About Us
Advertise
Contact Us
Editorial Info
Editorial Advisory Board
Do Not Sell My Personal Information
Privacy Policy
Terms and Conditions
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.